PG vs VRTV: Which Is the Better Buy?
Side-by-side comparison of The Procter & Gamble Company and Veritiv Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
VS
Veritiv Corporation · Industrials
$169.99
-45.0% upside to fair value
Med Conviction
Grade D
QuantHub Verdict
PG has more upside to fair value
(+14.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PG |
VRTV |
| Current Price |
$147.04 |
$169.99 |
| Fair Value Estimate |
$168.19 |
$93.49 |
| Upside to Fair Value |
+14.4%
|
-45.0%
|
| Market Cap |
$349.5B |
$2.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
17.6x
|
5.4x
|
| Price / Sales |
4.0x
|
0.4x
|
| Price / FCF |
22.4x
|
10.4x
|
| Revenue Growth YoY |
+1.5%
|
-19.0%
|
| Gross Margin |
50.2%
|
22.7%
|
| Operating Margin |
22.7%
|
5.9%
|
| Return on Equity |
29.8%
|
48.6%
|
| Dividend Yield |
2.92% |
1.48% |
| FCF Yield |
4.47%
|
9.57%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
| Metric |
PG |
VRTV |
| Zone Low |
$126.14 |
$70.12 |
| Zone High |
$142.96 |
$79.47 |
| In Buy Zone? |
No
|
No
|